Stay updated on Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The displayed record history list reflects a new submitted version dated 2026-04-17 with updates labeled for Contacts/Locations and Study Status, and it also shows an interface revision update to v3.5.3. An earlier revision reference (v3.5.2) is removed from the comparison list.
    Difference
    0.4%
    Check dated 2026-04-24T05:49:25.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the history.
    Difference
    0.1%
    Check dated 2026-04-17T02:20:45.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Version 35, submitted on 2026-03-16, adds updates to Study Status and Contacts/Locations and updates the record revision to v3.5.0.
    Difference
    0.4%
    Check dated 2026-03-19T04:48:59.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:40:26.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Version 34 updates the record by renaming the study to include Placebo With ADT and adding the Contacts/Locations, Study Design, Study Status, and Study Identification sections. These changes align the study's identification with the protocol and provide essential administrative details for tracking.
    Difference
    0.5%
    Check dated 2026-02-18T16:33:53.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history. Removed the government funding lapse notice and operating-status guidance that previously appeared on the page.
    Difference
    0.5%
    Check dated 2026-02-11T11:36:06.000Z thumbnail image

Stay in the know with updates to Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.